Skip to content

Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety

Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07427108
Enrollment
32
Registered
2026-02-23
Start date
2026-02-01
Completion date
2027-03-01
Last updated
2026-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease, Vascular Diseases

Brief summary

The study aims to compare the technical feasibility and safety of road mapping-guided versus ultrasound-guided retrograde arterial puncture in patients with (CLTI) as measured by: * Puncture success rate * Access-related complication rate (e.g., hematoma, vessel dissection, perforation)

Interventions

PROCEDURERoad-map guided versus US guided retrograde access

Road-map guided versus US guided retrograde access

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

-. 1. Adults : Both male and female participants. 2. Diagnosed with critical limp threatening ischemia (CLTI): significant occlusions in the femoropopliteal o Rutherford Class 5: Non-healing wounds or ulcers 3. Failed or unable to achieve antegrade access: Patients requiring retrograde puncture for the procedure. 4. Planned intervention with retrograde access: Candidates for endovascular interventions, including angioplasty, stent deployment

Exclusion criteria

• Active infection at the puncture site: Any localized infection, particularly over the ankle region , will be an exclusion. • Severe calcification or anatomical abnormalities: Patients with excessive arterial calcification or significant anatomical distortion preventing safe retrograde puncture.

Design outcomes

Primary

MeasureTime frame
Success rate12 months
Complication rate12 months

Countries

Egypt

Contacts

CONTACTYohana F Fayez, MBBCh
yohana_farouz_post@med.sohag.edu.eg+201288374728

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026